CompletedNCT00221429
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
BipolarityOtherFrom 7 Years to 18 Years
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Condition
- Bipolarity
CompletedNCT03360695
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Schizophrenia
CompletedNCT03509181
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Bipolarity
CompletedNCT04481737
This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand what helps a guided support group stay useful, realistic, and easier to follow over time.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Condition
- Depression
CompletedNCT03538275
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- Medibio Limited
- Condition
- Depression
CompletedNCT04477187
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
BipolarityOtherFrom 21 Years to 70 Years
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
- Condition
- Bipolarity
CompletedNCT03692910
This study exists to understand whether the medication SAGE-217 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SAGE-217 in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Biogen
- Condition
- Bipolarity
CompletedNCT03220776
This study exists to explore whether acceptance and commitment therapy, a talking treatment, could improve care and understanding. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can work better when mental health difficulties overlap with substance use.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Medical University of South Carolina
- Condition
- Bipolarity
CompletedNCT04987658
This study exists to better understand the safety of the medication OLZ and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication OLZ in practice and what may need to be adjusted.
BipolarityOtherFrom 10 Years to 12 Years
- Countries
- United States
- Sponsor
- Alkermes, Inc.
- Condition
- Bipolarity
CompletedNCT04030143
This study exists to better understand the safety of the medication Multiple-doses and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Multiple-doses in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity
CompletedNCT02466685
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Herbert Meltzer
- Condition
- Bipolarity
CompletedNCT03902613
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
BipolarityOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Bipolarity
TerminatedNCT06105294
This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand whether a medication treatment can improve sleep, daily rhythms, and longer-term stability.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, Berkeley
- Condition
- Bipolarity
WithdrawnNCT02811133
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherFrom 8 Years to 17 Years
- Countries
- United States
- Sponsor
- Ronald M. Glick, MD
- Condition
- Bipolarity
CompletedNCT03573297
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Malaysia, Poland, United States, Russian Federation, Serbia, South Korea, Taiwan, Thailand, Ukraine
- Sponsor
- AbbVie
- Condition
- Bipolarity
CompletedNCT04191876
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
CompletedNCT02478788
This study exists to see whether the medication Risk can play a useful role in care. Researchers are trying to understand whether the medication Risk can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 10 Years to 18 Years
- Countries
- United States
- Sponsor
- University of Cincinnati
- Condition
- Bipolarity
CompletedNCT04276883
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- BioXcel Therapeutics Inc
- Condition
- Bipolarity
CompletedNCT01431326
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherUp to 21 Years
- Countries
- Canada, Israel, Singapore, United Kingdom, United States
- Sponsor
- Daniel Benjamin
- Condition
- Schizophrenia
CompletedNCT03679962
This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 12 Years to 17 Years
- Countries
- United States
- Sponsor
- Billings Clinic
- Condition
- Depression
CompletedNCT01342380
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
DepressionOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- University Hospitals Cleveland Medical Center
- Condition
- Depression
TerminatedNCT04058249
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.
BipolarityOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- Stanford University
- Condition
- Bipolarity
CompletedNCT01065597
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Maryland, College Park
- Condition
- Depression
CompletedNCT04011280
This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT03543410
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Japan, Poland, Russian Federation, Serbia, Slovakia, Ukraine, United States
- Sponsor
- Sumitomo Pharma America, Inc.
- Condition
- Depression